---
$id: https://graph.org.ai/products/commodity/51111835
$type: Product
source: UNSPSC
code: "51111835"
title: "Benorterone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Benorterone

**UNSPSC Code**: 51111835
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C19H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J339Q7IM54, chemically known as b-norandrost-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)- but generally known as benorterone, which bears US NIH Compound Identifier 19126. European Medicines Agency schedules Benorterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05723MIG. The term BENORTERONE is an International Non-Proprietary Name. BENORTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benorterone under HS 29372900 and SITC 54153. As of Q4 2014, BENORTERONE remains the US FDA Preferred Term for this commodity. Benorterone bears US NLM identifiers UMLS ID C0053110 and NCI Concept Code C74121. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)C3)C)CC2)CC1)C)C.

